Forster Eliot
Insider CIK 1831558 · PLX Director · FSTX President and CEO, Director · IMTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 17,000 | — | $0 | 17,000 | SEC↗ |
| IMTX Immatics N.V. | A Award deriv | 2026-06-16 | 2026-06-18 | 48,000 | — | $0 | 48,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2025-09-03 | 2025-09-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2025-09-03 | 2025-09-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2023-09-14 | 2023-09-15 | 85,715 | — | $0 | 85,715 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 126,909 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 165,028 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 127,924 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | U Tender | 2023-03-08 | 2023-03-09 | 347,578 | $7.12 | $2.47M | 73,959 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer | 2023-03-08 | 2023-03-09 | 73,959 | $7.12 | $526.6K | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | M Exercise deriv | 2022-07-29 | 2022-08-02 | 32,602 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | M Exercise deriv | 2022-07-29 | 2022-08-02 | 228,375 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | M Exercise | 2022-07-29 | 2022-08-02 | 260,977 | $0.11 | $28.7K | 421,537 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 126,909 | — | $0 | 126,909 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2022-01-09 | 2022-01-11 | 165,028 | — | $0 | 165,028 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 127,924 | — | $0 | 388,901 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-02 | 142,000 | — | $0 | 160,560 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2020-11-20 | 2020-11-24 | 228,375 | — | $0 | 228,375 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2020-11-20 | 2020-11-24 | 32,602 | — | $0 | 32,602 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award | 2020-11-20 | 2020-11-24 | 18,560 | — | $0 | 18,560 | SEC↗ |